Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation
Autor: | Thomas Geeraerts, Philippe Leclerc, Hassan Salim, Marc Tardieu, Bénédicte Hugel, Jean-Marie Freyssinet, Christiane Hery, Kumaran Deiva |
---|---|
Rok vydání: | 2004 |
Předmět: |
N-Methylaspartate
p38 mitogen-activated protein kinases Excitotoxicity Apoptosis Biology Pertussis toxin medicine.disease_cause Neuroprotection Cell Line Tumor Calcium flux medicine Humans Extracellular Signal-Regulated MAP Kinases Protein kinase B Cells Cultured PI3K/AKT/mTOR pathway Neurons Chemokine CX3CL1 General Neuroscience Glutamate receptor Membrane Proteins Chemokines CX3C Cell biology Enzyme Activation nervous system Calcium |
Zdroj: | European Journal of Neuroscience. 20:3222-3232 |
ISSN: | 1460-9568 0953-816X |
DOI: | 10.1111/j.1460-9568.2004.03800.x |
Popis: | Our purpose was to investigate in human neurons the neuroprotective pathways induced by Fractalkine (FKN) against glutamate receptor-induced excitotoxicity. CX(3)CR1 and FKN are expressed constitutively in the tested human embryonic primary neurons and SK-N-SH, a human neuroblastoma cell line. Microfluorometry assay demonstrated that CX(3)CR1 was functional in 44% of primary neurons and in 70% of SK-N-SH. Fractalkine induced ERK1/2 phosphorylation within 1 min and Akt phosphorylation after 10 min, and both phosphorylation decreased after 20 min. No p38 and SAPK/JNK activation was observed after FKN treatment. Application of FKN triggered a 53% reduction of the NMDA-induced neuronal calcium influx, which was insensitive to pertussis toxin and LY294002 an inhibitor of Akt pathway, but abolished by PD98059, an ERK1/2 pathway inhibitor. Moreover, FKN significantly reduced neuronal NMDA-induced apoptosis, which was pertussis toxin insensitive and abolished in presence of PD98059 and LY294002. In conclusion, FKN protected human neurons from NMDA-mediated excitotoxicity in at least two ways with different kinetics: (i) an early ERK1/2 activation which reduced NMDA-mediated calcium flux; and (ii), a late Akt activation associated with the previously induced ERK1/2 activation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |